Follow
Dr. Kylie Ainslie
Dr. Kylie Ainslie
Dutch National Institute for Public Health and the Environment (RIVM)
Verified email at rivm.nl
Title
Cited by
Cited by
Year
Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand
NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ...
Imperial College London, 2020
49112020
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ...
Nature 584 (7820), 257-261, 2020
39212020
The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries
PGT Walker, C Whittaker, OJ Watson, M Baguelin, P Winskill, A Hamlet, ...
Science 369 (6502), 413-422, 2020
9102020
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study
AB Hogan, BL Jewell, E Sherrard-Smith, JF Vesga, OJ Watson, ...
The Lancet global health 8 (9), e1132-e1141, 2020
8042020
The global impact of COVID-19 and strategies for mitigation and suppression
PGT Walker, C Whittaker, O Watson, M Baguelin, KEC Ainslie, S Bhatia, ...
Imperial College London 26, 1-19, 2020
6872020
Reduction in mobility and COVID-19 transmission
P Nouvellet, S Bhatia, A Cori, KEC Ainslie, M Baguelin, S Bhatt, ...
Nature communications 12 (1), 1-9, 2021
5402021
Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College COVID-19 Response Team
NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ...
Imperial College COVID-19 Response Team 20 (10.25561), 77482, 2020
3732020
Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study
NC Grassly, M Pons-Salort, EPK Parker, PJ White, NM Ferguson, ...
The Lancet Infectious Diseases 20 (12), 1381-1389, 2020
2022020
Response to COVID-19 in South Korea and implications for lifting stringent interventions
A Dighe, L Cattarino, G Cuomo-Dannenburg, J Skarp, N Imai, S Bhatia, ...
BMC medicine 18, 1-12, 2020
1912020
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic
H Ward, C Atchison, M Whitaker, KEC Ainslie, J Elliott, L Okell, R Redd, ...
Nature communications 12 (1), 905, 2021
1812021
State-level tracking of COVID-19 in the United States
HJT Unwin, S Mishra, VC Bradley, A Gandy, TA Mellan, H Coupland, ...
Nature communications 11 (1), 6189, 2020
1712020
Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment
KEC Ainslie, CE Walters, H Fu, S Bhatia, H Wang, X Xi, M Baguelin, ...
Wellcome Open Research 5, 2020
1482020
Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults
H Ward, G Cooke, C Atchison, M Whitaker, J Elliott, M Moshe, JC Brown, ...
MedRxiv, 2020.10. 26.20219725, 2020
1412020
Report 21: Estimating COVID-19 cases and reproduction number in Brazil
TA Mellan, HH Hoeltgebaum, S Mishra, C Whittaker, RP Schnekenberg, ...
1392020
Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults
H Ward, CJ Atchison, M Whitaker, KEC Ainslie, J Elliott, LC Okell, R Redd, ...
1362020
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant
P Elliott, D Haw, H Wang, O Eales, CE Walters, KEC Ainslie, C Atchison, ...
Science 374 (6574), eabl9551, 2021
1102021
Resurgence of SARS-CoV-2: detection by community viral surveillance
S Riley, KEC Ainslie, O Eales, CE Walters, H Wang, C Atchison, ...
Science 372 (6545), 990-995, 2021
952021
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults
H Ward, GS Cooke, C Atchison, M Whitaker, J Elliott, M Moshe, JC Brown, ...
The Lancet Regional Health–Europe 4, 2021
812021
Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults
H Ward, C Atchison, M Whitaker, KEC Ainslie, J Elliott, L Okell, R Redd, ...
MedRxiv, 2020.08. 12.20173690, 2020
782020
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B. 1.617. 2), the Netherlands, August to September 2021
B de Gier, S Andeweg, JA Backer, SJM Hahné, S van den Hof, ...
Eurosurveillance 26 (44), 2100977, 2021
772021
The system can't perform the operation now. Try again later.
Articles 1–20